Interim Results and Directorate Change

TruFin posts strong interim results, delivers major capital returns, and targets 2027 profitability.

What the company is saying

TruFin plc presents a narrative of operational and financial improvement, highlighting an 11% rise in group gross revenue to £5.9m and a 17% increase in net revenue to £5.3m for H1 2026. The company stresses the successful sale of Playstack for an enterprise value of £125m, resulting in £74.9m profit from discontinued operations and net proceeds of £112.4m, which enabled significant capital returns: a £56.8m tender offer and a £22.5m special dividend. Segmentally, Oxygen's revenue grew 12% to £4.9m with EBITDA up 30% to £2.1m, while Satago's revenue jumped 41% to £1.0m and subscriptions surged 260% to 4,621, with Satago achieving EBITDA profitability in June 2026. The announcement frames these results as evidence of strong execution, recurring revenue growth, and disciplined cost management, with CEO James van den Bergh emphasizing the company's robust cash position and readiness for bolt-on acquisitions or further capital returns. The tone is confident, with forward-looking statements focused on achieving group profitability in 2027 and Satago's full-year EBITDA profitability in 2026. Sean Brennan's departure as Non-Executive Director is positioned as a planned transition following the Playstack sale.

What the data suggests

The disclosed figures show clear operational momentum: group gross revenue rose to £5,878,000 from £5,280,000, net revenue increased to £5,335,000 from £4,552,000, and adjusted EBITDA swung from a loss of £81,000 to a profit of £483,000. Loss before tax narrowed by 24% to £1,449,000. Oxygen's gross revenue climbed to £4.9m and EBITDA to £2.1m, while Satago's gross revenue reached £1.0m and subscriptions rose from 1,777 to 4,621. The Playstack sale generated £74.9m profit from discontinued operations and net proceeds of £112.4m, boosting net assets to £123.9m. Capital returns were substantial: 4,486,377 shares bought back for £6.0m, a tender offer for 40,579,562 shares at 140p (£56.8m), and a £22.5m special dividend. Operational KPIs improved, with 65% of Oxygen's Early Payment clients using multiple products, £454m paid early through FreePay, and partnership revenues more than doubling. Forward-looking statements about Satago's profitability and group targets are grounded in recent trends but not yet realised. The evidence supports a narrative of improving financial health and operational leverage, with most capital returns already executed.

Analysis

The announcement is strongly positive in tone but is well-supported by realised, detailed financial and operational data. Key improvements—such as revenue growth, adjusted EBITDA turning positive, and a substantial profit from the Playstack disposal—are all evidenced by disclosed numbers. Forward-looking statements (e.g., Satago's expected full-year EBITDA profitability, group profitability targeted for 2027) are present but limited in number and are proportionate to the operational momentum shown. There is no evidence of exaggerated claims or narrative inflation: most statements are factual, and future targets are framed as expectations rather than certainties. The capital returns (buybacks, special dividend) are already executed, not merely promised. No large capital outlay is paired with only long-dated, uncertain returns; instead, realised cash inflows from the Playstack sale have already been distributed. The gap between narrative and evidence is minimal.

Risk flags

• ●Despite improved adjusted EBITDA, the group remains loss-making at the statutory level, with a £1.45m loss before tax for H1 2026. Achieving full-year profitability in 2027 depends on continued revenue growth and cost discipline, and any reversal could delay this target.
• ●Satago's EBITDA profitability is recent and not yet proven over a full year. The business model shift to Lending-as-a-Service and expansion into new markets introduces execution risk, especially as Satago transitions away from core servicing.
• ●Oxygen's growth relies heavily on public sector contracts and recurring revenue streams. Changes in procurement policy, increased competition, or client attrition could impact future revenue and margin stability.
• ●A large portion of the company's recent profit and capital returns stem from the one-off Playstack disposal. The sustainability of future returns will depend on the performance of the remaining businesses and the success of any new acquisitions.
• ●The company has signaled a willingness to return further capital if suitable acquisitions are not found. This introduces strategic risk: failure to deploy cash into growth assets could limit long-term upside, while poorly executed acquisitions could erode value.

Bottom line

TruFin's interim results demonstrate strong operational improvement, a transformed balance sheet, and substantial capital returns following the Playstack sale. The company is executing on its stated strategy, with Oxygen and Satago both delivering revenue growth and improved profitability metrics, and Satago now EBITDA positive. The cash windfall from Playstack has already been largely returned to shareholders through a tender offer and special dividend, reducing the risk of capital allocation drift. However, the group remains loss-making on a statutory basis, and the transition to full-year profitability in 2027 is not yet assured. Satago's business model shift and Oxygen's reliance on public sector contracts present ongoing execution and market risks. Investors should focus on evidence of sustained profitability in Satago, continued cash generation from Oxygen, and the outcome of any acquisition or further capital return decisions. The most important takeaway is that TruFin is now a leaner, cash-rich group with a credible path to profitability, but future value creation will hinge on disciplined execution and strategic clarity.

Announcement summary

(LSE:TRU) TruFin plc announced its unaudited interim results for the six months ended 30 June 2026. Group gross revenue increased by 11% to £5.9m compared to £5.3m in H1 2025. Net revenue rose 17% to £5.3m from £4.6m in H1 2025. Adjusted EBITDA improved by £0.6m to £0.5m, compared with a £0.1m loss in the same period in 2025. Loss before tax improved by 24% to £1.5m (H1 2025: £1.9m). Gross revenue at Oxygen increased by 12% to £4.9m (H1 2025: £4.4m), with EBITDA up 30% to £2.1m (H1 2025: £1.6m). Gross revenue at Satago increased 41% to £1.0m (H1 2025: £0.7m), and Satago turned EBITDA profitable in June 2026. Satago subscriptions grew 260% year-on-year to 4,621 (H1 2025: 1,777). Profit from discontinued operations was £74.9m following the sale of Playstack Limited and its subsidiaries, which completed on 10 June 2026. The Playstack disposal represented an enterprise value of £125m, with net proceeds of approximately £112.4m received by the Group, including a £1.5m holdback for potential tax liabilities and repayment of a £15.6m loan. In January 2026, TruFin commenced its third share buyback programme in 12 months, purchasing 4,486,377 shares at an average price of 123.0p, with a maximum aggregate consideration of £6.0m; the buyback was terminated in May 2026. Following the Playstack sale, a proposed return of £80m to shareholders was announced. In July 2026, the Company completed a tender offer, purchasing 40,579,562 shares at 140p per share, returning approximately £56.8m to shareholders. In August 2026, a special dividend of approximately £22.5m (43.03p per share) was paid to shareholders. More than 65% of Oxygen's Early Payment clients purchased two or more products (H1 2025: 53%). Oxygen returned £1.35m to TruFin (H1 2025: £1.0m), an increase of 35%. During H1 2026, £454m was paid early through Oxygen's FreePay initiative across more than 150,000 invoices from over 22,000 suppliers. UK EP revenue at Oxygen grew by 17% in H1 2026, with new signed supplier spend at £362m (c.50% increase over H1 2025), and net signed annual supplier spend exceeding £2.1bn at period end. Partnership revenues at Oxygen more than doubled year-on-year. Post-period, aggregate gross revenues for July and August 2026 are expected to be more than £2.1m, representing 28% year-on-year growth. Satago is expected to be EBITDA profitable in the second half, and Oxygen is set to continue profitable growth. The Group is trading in line with expectations and is expected to be loss-making for the full year 2026, with a target of achieving full-year profitability in 2027. As at 30 June 2026, net assets were £123.9m (H1 2025: £47.8m). TruFin continues to hold 97.70% of Satago. Sean Brennan (NED) stepped down from the Board following the Playstack sale. The Board continues to assess bolt-on and new platform acquisitions and may return further capital to shareholders if suitable targets are not found.

Disagree with this article?